Doxycycline hyclate controlled release (Polypid)

盐酸多西环素控释制剂 (Polypid)

Report date: 2026/03/04 20:01:44

Base Information

Drug NameDoxycycline hyclate controlled release (Polypid)
Drug Alias NameDoxycycline/polymer-lipid encapsulation matrixPLEX-doxycyclineD-PLEXD-PLEX-100
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsMatrix metalloproteinase inhibitors
Targets30S ribosomal subunitMatrix metalloproteinase
Therapy Area/IndicationsSurgical Wound Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBosnia and HerzegovinaBulgaria +[17] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPolypid Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPolypid Ltd
Inactive CompaniesN/A
Active IndicationsSurgical Wound Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A